| 2025 | 2024 | |||
|---|---|---|---|---|
| Gross margin | 239,4 k € | -26.3% | 324,8 k € | |
| EBITDA | 238,7 k € | -26.4% | 324,4 k € | |
| Operating profit | 193,5 k € | -32.2% | 285,1 k € | |
| Profit/loss | 139,4 k € | -33.8% | 210,5 k € | |
| Equity | 351,3 k € | +65.1% | 212,7 k € | |
| Total assets | 691,5 k € | +10.1% | 628,3 k € | |
| Cash | 341,6 k € | +63.3% | 209,2 k € | |
| Debts | 340,2 k € | -18.1% | 415,6 k € | |
Source: Belgian Official Gazette
Private limited company profitable and well capitalised. Cash position rising (+63.3%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
MedimAG is a Private limited company incorporated in 2024. Its registered office is in Ath.